Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Equity Average: 2010-2024

Historic Equity Average for Cumberland Pharmaceuticals (CPIX) over the last 15 years, with Dec 2024 value amounting to $26.2 million.

  • Cumberland Pharmaceuticals' Equity Average rose 5.83% to $27.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.1 million, marking a year-over-year increase of 5.83%. This contributed to the annual value of $26.2 million for FY2024, which is 20.36% down from last year.
  • Cumberland Pharmaceuticals' Equity Average amounted to $26.2 million in FY2024, which was down 20.36% from $32.9 million recorded in FY2023.
  • Cumberland Pharmaceuticals' Equity Average's 5-year high stood at $49.1 million during FY2020, with a 5-year trough of $26.2 million in FY2024.
  • In the last 3 years, Cumberland Pharmaceuticals' Equity Average had a median value of $32.9 million in 2023 and averaged $32.9 million.
  • Data for Cumberland Pharmaceuticals' Equity Average shows a maximum YoY dropped of 20.36% (in 2024) over the last 5 years.
  • Yearly analysis of 5 years shows Cumberland Pharmaceuticals' Equity Average stood at $49.1 million in 2020, then dropped by 8.47% to $44.9 million in 2021, then decreased by 11.94% to $39.5 million in 2022, then fell by 16.71% to $32.9 million in 2023, then fell by 20.36% to $26.2 million in 2024.